AIP Stock Price, Arteris, Inc. Quote, Chart

Market Summary

USD6.59-0.16

Delayedas of 18 Apr 2024, 03:02 pm

-2.37%

AIP Stock Price

View Fullscreen

AIP RSI Chart

AIP Valuation

Market Cap

255.5M

Price/Earnings (Trailing)

-6.93

Price/Sales (Trailing)

4.76

EV/EBITDA

-8.48

Price/Free Cashflow

-14.83

AIP Price/Sales (Trailing)

AIP Profitability

EBT Margin

-59.25%

Return on Equity

-244.12%

Return on Assets

-35.86%

Free Cashflow Yield

-6.74%

AIP Fundamentals

AIP Revenue

Revenue (TTM)

53.7M

Rev. Growth (Yr)

11.61%

Rev. Growth (Qtr)

-5.8%

AIP Earnings

Earnings (TTM)

-36.9M

Earnings Growth (Yr)

-46.1%

Earnings Growth (Qtr)

-29.29%

Breaking Down AIP Revenue

52 Week Range

3.578.08

(Low)(High)

Last 7 days

-9.1%

Last 30 days

7.0%

Last 90 days

32.8%

Trailing 12 Months

77.9%

How does AIP drawdown profile look like?

AIP Financial Health

Current Ratio

1.26

AIP Investor Care

Shares Dilution (1Y)

9.31%

Diluted EPS (TTM)

-1.03

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	51.8M	51.7M	52.4M	53.7M
2022	43.0M	47.0M	50.6M	50.4M
2021	33.3M	34.8M	36.4M	37.9M
2020	0	0	0	31.8M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Arteris, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 11, 2024	hawkins nicholas b.	sold	-72,161	7.2161	-10,000	vp and chief financial officer
Apr 05, 2024	viana antonio j	acquired	-	-	2,781	-
Apr 04, 2024	hawkins nicholas b.	sold	-16,323	7.2809	-2,242	vp and chief financial officer
Apr 03, 2024	alpern paul l	sold	-23,625	7.1766	-3,292	vp and general counsel
Apr 03, 2024	moll laurent r	sold	-4,166	7.1721	-581	chief operating officer
Apr 02, 2024	alpern paul l	sold	-17,601	7.0267	-2,505	vp and general counsel
Apr 02, 2024	janac k charles	sold	-71,000	7.02763	-10,103	president and ceo
Apr 02, 2024	moll laurent r	sold	-29,448	7.0267	-4,191	chief operating officer
Apr 02, 2024	hawkins nicholas b.	sold	-24,108	7.0267	-3,431	vp and chief financial officer
Apr 01, 2024	alpern paul l	sold	-81,512	7.24556	-11,250	vp and general counsel

Which funds bought or sold AIP recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 05, 2024	CWM, LLC	reduced	-12.88	-	1,000	-%
Mar 11, 2024	VANGUARD GROUP INC	added	16.83	363,080	6,732,160	-%
Mar 01, 2024	GOLDMAN SACHS GROUP INC	new	-	206,952	206,952	-%
Feb 20, 2024	EVENTIDE ASSET MANAGEMENT, LLC	unchanged	-	-247,395	2,350,240	0.04%
Feb 16, 2024	GSA CAPITAL PARTNERS LLP	added	8.76	-10,000	617,000	0.05%
Feb 15, 2024	JANE STREET GROUP, LLC	added	937	593,477	664,215	-%
Feb 15, 2024	BARCLAYS PLC	added	138	139,000	259,000	-%
Feb 14, 2024	JACOBS LEVY EQUITY MANAGEMENT, INC	added	8.64	-23,460	1,350,240	0.01%
Feb 14, 2024	AMERIPRISE FINANCIAL INC	reduced	-13.2	-281,616	1,030,040	-%
Feb 14, 2024	KENNEDY CAPITAL MANAGEMENT LLC	sold off	-100	-493,067	-	-%

Are Funds Buying or Selling AIP?

Are funds buying AIP calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own AIP

No. of Funds

Unveiling Arteris, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Jan 24, 2024	ventech capital f	5.6%	2,054,782	SC 13G/A
Jan 24, 2024	bayview legacy, llc	28.0%	10,307,691	SC 13G/A
Feb 08, 2023	ventech capital f	9.3%	3,111,046	SC 13G/A
Feb 08, 2023	bayview legacy, llc	30.9%	10,323,891	SC 13G/A
Feb 10, 2022	bayview legacy, llc	33.1%	10,335,891	SC 13G
Feb 10, 2022	ventech capital f	10.0%	3,127,907	SC 13G

Recent SEC filings of Arteris, Inc.

View All Filings

Date Filed	Form Type	Document
Apr 15, 2024	4	Insider Trading
Apr 09, 2024	4	Insider Trading
Apr 04, 2024	144	Notice of Insider Sale Intent
Apr 04, 2024	4	Insider Trading
Apr 04, 2024	4	Insider Trading
Apr 04, 2024	4	Insider Trading
Apr 04, 2024	4	Insider Trading
Apr 03, 2024	144	Notice of Insider Sale Intent
Apr 03, 2024	144	Notice of Insider Sale Intent
Apr 02, 2024	144	Notice of Insider Sale Intent

Peers (Alternatives to Arteris, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
NVDA	2.1T	60.9B	-4.99%	203.77%	70.6	34.49	125.85%	581.31%
AMD	248.8B	22.7B	-19.22%	71.54%	291.39	10.97	-3.90%	-35.30%
AMAT	166.2B	26.5B	-0.37%	79.72%	23.22	6.27	0.88%	10.98%
INTC	150.9B	54.2B	-16.44%	12.13%	89.34	2.78	-14.00%	-78.92%
ADI	93.9B	11.6B	-0.94%	-0.08%	33.36	8.12	-8.03%	-17.90%
MID-CAP
AMKR	7.4B	6.5B	-3.09%	25.28%	20.57	1.14	-8.30%	-53.02%
CRUS	4.6B	1.8B	-4.11%	-4.03%	26.12	2.57	-11.16%	-46.12%
ACLS	3.3B	1.1B	-7.81%	-21.22%	13.48	2.94	22.89%	34.51%
DIOD	3.1B	1.7B	2.33%	-21.68%	13.58	1.86	-16.94%	-31.42%
AMBA	1.8B	226.5M	-11.43%	-36.15%	-10.56	7.9	-32.92%	-159.10%
SMALL-CAP
ACMR	1.7B	557.7M	-2.65%	168.24%	21.71	3.01	43.44%	97.00%
AOSL	584.2M	640.0M	-1.29%	-19.84%	-34.07	0.91	-19.44%	-128.49%
AEHR	322.4M	71.9M	-23.21%	-63.36%	20.93	4.48	14.14%	8.17%
ATOM	150.1M	550.0K	-4.07%	6.20%	-7.59	272.98	43.98%	-13.47%
ASYS	67.4M	116.7M	0.21%	-46.63%	-3.51	0.58	15.07%	-240.88%

Arteris, Inc. News

Latest updates

Arteris, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)														(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3
Revenue	-5.8%	12,504,000	13,274,000	14,734,000	13,154,000	11,203,000	12,598,000	14,822,000	11,755,000	11,434,000	8,959,000	10,813,000	6,658,000	6,543,500	6,429,000
Gross Profit	-7.8%	11,056,000	11,994,000	13,509,000	12,030,000	10,118,000	11,670,000	13,533,000	10,776,000	10,321,000	8,076,000	9,946,000	5,790,000	-	6,202,000
Operating Expenses	-0.7%	20,305,000	20,447,000	22,192,000	20,787,000	19,178,000	19,424,000	18,959,000	17,392,000	17,601,000	12,593,000	13,467,000	12,237,000	-	8,821,000
S&GA Expenses	0.1%	5,029,000	5,024,000	5,601,000	5,005,000	4,631,000	4,411,000	4,456,000	3,921,000	3,755,000	3,242,000	2,281,000	2,448,000	-	2,240,000
R&D Expenses	-3.0%	10,663,000	10,997,000	12,087,000	11,381,000	10,318,000	11,022,000	10,371,000	9,456,000	10,240,000	7,609,000	6,425,000	6,538,000	-	4,011,000
EBITDA Margin	2.4%	-0.53	-0.54	-0.56	-0.51	-0.50	-0.49	-0.47	-0.49	-0.55	-0.03	-0.04	-0.04	-0.04	-
Interest Expenses	-2.6%	75,000	77,000	27,000	32,000	29,000	22,000	18,000	20,000	-	-	-	-	-	-
Income Taxes	401.0%	1,198,000	-398,000	556,000	300,000	-1,116,500	248,000	351,000	100,000	412,000	268,000	188,000	200,000	-	1,199,000
Earnings Before Taxes	-10.2%	-8,407,000	-7,632,000	-7,875,000	-7,881,000	-8,070,000	-7,436,000	-5,317,000	-6,697,000	-7,362,000	-4,700,000	-3,721,000	-6,561,000	-	-2,645,000
EBT Margin	1.4%	-0.59	-0.60	-0.60	-0.55	-0.55	-0.53	-0.51	-0.52	-0.59	-0.06	-0.06	-0.07	-0.07	-
Net Income	-29.3%	-10,541,000	-8,153,000	-9,165,000	-9,010,000	-7,215,000	-7,684,000	-5,668,000	-6,820,000	-7,790,000	-4,968,000	-3,909,000	-6,717,000	-	-3,844,000
Net Income Margin	-7.3%	-0.69	-0.64	-0.64	-0.57	-0.54	-0.55	-0.54	-0.55	-0.62	-0.09	-0.09	-0.10	-0.10	-
Free Cashflow	-8.3%	-3,407,000	-3,146,000	-2,170,000	-8,509,000	-787,000	-5,663,000	85,000	-1,453,000	2,872,000	-2,629,000	-2,342,000	477,000	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet											(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2020Q4
Assets	0.6%	103	102	107	107	116	119	121	112	120	41.00	43.00
Current Assets	-5.7%	58.00	62.00	70.00	76.00	81.00	91.00	95.00	99.00	107	24.00	29.00
Cash Equivalents	-26.5%	14.00	19.00	26.00	29.00	37.00	68.00	81.00	82.00	86.00	11.00	12.00
Net PPE	5.8%	6.00	5.00	5.00	3.00	4.00	4.00	3.00	2.00	2.00	2.00	2.00
Goodwill	0%	4.00	4.00	4.00	4.00	4.00	3.00	3.00	3.00	3.00	3.00	3.00
Liabilities	9.4%	88.00	80.00	80.00	76.00	78.00	78.00	75.00	65.00	68.00	56.00	49.00
Current Liabilities	4.2%	46.00	45.00	44.00	41.00	44.00	44.00	43.00	40.00	42.00	37.00	28.00
Shareholder's Equity	-31.4%	15.00	22.00	27.00	32.00	38.00	40.00	46.00	48.00	53.00	-	-
Retained Earnings	-11.4%	-103	-92.71	-84.55	-75.39	-66.38	-59.16	-51.48	-45.81	-38.99	-31.20	-15.61
Additional Paid-In Capital	3.1%	118	115	111	107	104	100	97.00	94.00	92.00	11.00	4.00
Shares Outstanding	1.9%	38.00	37.00	36.00	35.00	35.00	33.00	32.00	32.00	32.00	21.00	18.00
Float	-	-	-	163	-	-	-	144	-	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)														(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3
Cashflow From Operations	-6.2%	-2,979	-2,806	-1,555	-8,389	-391	-5,213	198	-1,361	3,192	-2,500	-2,022	516	-	-
Share Based Compensation	-4.3%	3,554	3,714	4,282	2,985	2,610	3,389	3,384	2,309	4,366	433	378	333	-	-
Cashflow From Investing	63.0%	-1,368	-3,694	-50.00	421	-30,148	-6,608	-442	-283	-871	-129	-320	-39.00	-	-
Cashflow From Financing	51.6%	-584	-1,207	-178	-950	-238	-1,280	-691	-1,945	72,263	-939	5,130	-200	-	-

AIP Income Statement

2023-12-31

Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (36,869)	$ (27,387)
Other comprehensive loss:
Unrealized gains (losses) on available-for-sale securities, net of tax	93	(53)
Unrealized pension actuarial (loss) gain	(74)	235
Comprehensive loss	$ (36,850)	$ (27,205)

AIP Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 13,696	$ 37,423
Short-term investments (Note 5)	27,477	30,728
Accounts receivable, net of allowance of $93 and $250 as of December 31, 2023 and 2022, respectively	12,003	7,143
Prepaid expenses and other current assets	5,254	5,818
Total current assets	58,430	81,112
Property and equipment, net	5,745	3,617
Long-term investments (Note 5)	11,802	4,427
Equity method investment	8,500	11,897
Operating lease right-of-use assets	4,289	1,883
Intangibles, net	3,858	4,575
Goodwill	4,178	4,218
Other assets	5,999	3,787
TOTAL ASSETS	102,801	115,516
Current liabilities:
Accounts payable	183	572
Accrued expenses and other current liabilities	11,831	12,095
Operating lease liabilities, current	781	899
Deferred revenue, current	31,537	28,839
Vendor financing arrangements, current	2,070	1,264
Total current liabilities	46,402	43,669
Deferred revenue, noncurrent	25,172	21,840
Operating lease liabilities, noncurrent	3,610	1,009
Vendor financing arrangements, noncurrent	1,292	448
Deferred income, noncurrent	8,810	9,993
Other liabilities	2,412	1,022
Total liabilities	87,698	77,981
Commitments and contingencies (Note 12)
Stockholders’ equity:
Preferred stock, par value of $0.001—10,000,000 shares authorized and no shares issued and outstanding as of both December 31, 2023 and 2022	0	0
Common stock, par value of $0.001—300,000,000 shares authorized at December 31, 2023 and 2022; 37,518,583 and 34,625,875 shares issued and outstanding at December 31, 2023 and 2022, respectively	37	34
Additional paid-in capital	118,193	103,778
Accumulated other comprehensive income	120	101
Accumulated deficit	(103,247)	(66,378)
Total stockholders’ equity	15,103	37,535
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 102,801	$ 115,516

About Arteris, Inc.

Arteris, Inc. provides semiconductor interconnect intellectual property (IP) and IP deployment solutions in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in System-on-Chip (Soc) designs and Network-on-Chip (NoC) interconnect IP. Its products include FlexNoC and FlexWay silicon-proven interconnect IP products; Ncore, a silicon-proven and cache coherent interconnect IP product that provides scalable, configurable, and area efficient characteristics; and CodaCache, a last-level cache semiconductor IP product. The company also offers IP deployment products comprising Magillem Connectivity that shortens and streamlines the SoC integration process; Magillem Registers and CSRCompiler that addresses hardware-software integration challenges for SoCs; and Harmony Trace that provides an enterprise-level server-based application with a web-based user interface. The company serves semiconductor manufacturers, original equipment manufacturers, hyperscale system houses, semiconductor design houses, and other producers of electronic systems. Arteris, Inc. was founded in 2003 and is headquartered in Campbell, California.

CEO	Mr. Karel Charles Janac
WEBSITE	arteris.com
INDUSTRY	Semiconductors
EMPLOYEES	248

Arteris, Inc. Frequently Asked Questions

What is the ticker symbol for Arteris, Inc.? What does AIP stand for in stocks?

AIP is the stock ticker symbol of Arteris, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Arteris, Inc. (AIP)?

As of Wed Apr 17 2024, market cap of Arteris, Inc. is 255.49 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AIP stock?

You can check AIP's fair value in chart for subscribers.

What is the fair value of AIP stock?

You can check AIP's fair value in chart for subscribers. The fair value of Arteris, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Arteris, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for AIP so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Arteris, Inc. a good stock to buy?

The fair value guage provides a quick view whether AIP is over valued or under valued. Whether Arteris, Inc. is cheap or expensive depends on the assumptions which impact Arteris, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AIP.

What is Arteris, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Apr 17 2024, AIP's PE ratio (Price to Earnings) is -6.93 and Price to Sales (PS) ratio is 4.76. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AIP PE ratio will change depending on the future growth rate expectations of investors.